Online Quality Control, Hyperfractionated Radiotherapy Alone and Reduced Boost Volume for Standard Risk Medulloblastoma: Long-Term Results of MSFOP 98 | Zendy

C. Carrié | Zendy; Jacques Grill | Zendy; Dominique FigarellaBranger | Zendy; V. Bernier | Zendy; Laëtitia Padovani | Zendy; Jean Louis Habrand | Zendy; M. Ben-Hassel | Zendy; Martine Mege | Zendy; M.-A. Mahé | Zendy; Philippe Quétin | Zendy; Jean Philippe Maire | Zendy; Marie Baron | Zendy; P. Clavère | Zendy; S. Chapet | Zendy; P. Maingon | Zendy; Claire Alapetite | Zendy; L. Claude | Zendy; Anne Laprie | Zendy; Sophie Dussart | Zendy

Open Access

Online Quality Control, Hyperfractionated Radiotherapy Alone and Reduced Boost Volume for Standard Risk Medulloblastoma: Long-Term Results of MSFOP 98

Author(s) -

C. Carrié,

Jacques Grill,

Dominique FigarellaBranger,

V. Bernier,

Laëtitia Padovani,

Jean Louis Habrand,

M. Ben-Hassel,

Martine Mege,

M.-A. Mahé,

Philippe Quétin,

Jean Philippe Maire,

Marie Baron,

P. Clavère,

S. Chapet,

P. Maingon,

Claire Alapetite,

L. Claude,

Anne Laprie,

Sophie Dussart

Publication year - 2009

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2008.18.6437

Subject(s) - medicine , medulloblastoma , cohort , radiation therapy , nuclear medicine , cancer research

To determine event free and overall survival, and long-term cognitive sequelae of children with standard-risk medulloblastoma (SRM) treated with hyperfractionated radiotherapy, conformal reduced boost volume without chemotherapy, and online quality assurance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research